Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A blood pressure cuff and stethoscope in a clinical setting

May 27, 2026

Cardio Diagnostics Holdings (NASDAQ: CDIO) Showcases AI-Powered Cardiovascular Risk Solutions at Four National Benefits Conferences

Cardio Diagnostics Holdings (NASDAQ: CDIO) is set to present its innovative AI-driven cardiovascular risk solutions at four national benefits conferences in June, targeting key stakeholders in healthcare management.The company aims to engage employers, brokers, union trustees, and plan administrators to address the significant impact of cardiovascular disease on health plan costs and workforce productivity. At these conferences, Cardio Diagnostics will showcase its advanced offerings, including
A minimalist illustration of a dollar sign and a coin in a dark palette.

May 27, 2026

Cypher AI Raises $2M in Seed Funding

Cypher AI, a company focused on AI-driven digital infrastructure for life sciences R&D, has successfully secured $2 million in Seed funding.This funding round was led by MaC Venture Capital, with contributions from several investors including Epsilon Ventures, Connecticut Innovations, Sparta Group, and LiquidMetal Ventures. The capital will be directed towards enhancing the company's operations and advancing its development projects.Founded in 2025 by Yaoyu Yang, Cypher AI aims to transform the
Minimalist illustration of a brain with neuroimaging scan

May 27, 2026

Multiple Sclerosis Diagnostics Market Size to Hit USD 12.88 Billion by 2035

The global multiple sclerosis diagnostics market is projected to experience significant growth, reaching USD 12.88 billion by 2035, driven by technological advancements in neuroimaging and a growing emphasis on early diagnosis.In 2025, the market size is estimated at USD 5.70 billion, with an anticipated increase to USD 6.20 billion in 2026. The compound annual growth rate (CAGR) from 2026 to 2035 is expected to be 8.80%. North America currently leads the market, holding a 40% share, while the A
A medical notebook and pen on a wooden table in a clinical workspace

May 27, 2026

Tata Elxsi launches AnaTel, an AI native software development platform

Tata Elxsi has introduced AnaTel, a pioneering AI-native software development platform tailored for healthcare and medical technology sectors, in collaboration with OpenAna. This launch occurred at DeviceTalks Boston 2026, showcasing advancements in AI-driven MedTech engineering and compliance.The healthcare and medtech industries are currently grappling with increasing regulatory demands, particularly concerning AI-enabled device software. Upcoming guidance from the FDA and Europe's MDCG emphas
Flat illustration of microRNA and protein biomarkers

May 27, 2026

Aspira Women’s Health and Cleveland Clinic Expand Collaboration on AI-Powered Diagnostics for Ovarian Cancer and Endometriosis

Aspira Women’s Health has partnered with Cleveland Clinic to enhance AI-driven diagnostics aimed at ovarian cancer and endometriosis. This collaboration seeks to leverage advanced biomarker discovery and analytical models to improve women’s health diagnostics.The partnership will focus on developing non-invasive tests, building on Aspira's existing OvaSuite, which helps assess ovarian cancer risk for over a million American women annually. Plans include expanding their diagnostic offerings by in
A bioreactor in a dimly lit biotechnology lab, showcasing lab equipment in the background.

May 27, 2026

Nocera: Up To $300 Million Facility Expanded For AI, Data Centers, Robotics, Biotech And Digital Assets Strategy

Nocera is set to transition into Nocera Holdings, a diversified technology company focusing on sectors like AI, biotech, and digital assets, backed by a $300 million financing facility.The strategic shift aims to capitalize on emerging markets in artificial intelligence, data centers, and robotics. Nocera plans to utilize the amended financing to pursue acquisitions and partnerships that enhance its presence in rapidly evolving technological sectors. The company is particularly focused on AI pla
A minimalist representation of a stock chart and dollar sign symbolizing financial growth.

May 27, 2026

Doximity’s AI Investment Year Has Arrived: Is Doximity Stock Undervalued at $20 or Not

Doximity's recent earnings report has sparked discussions about its stock valuation, particularly in light of its significant AI investments. Following a revenue guidance miss for FY27, Doximity's stock price has dropped to around $20, raising questions about whether it is undervalued.In its fiscal Q4 2026 earnings, Doximity reported a revenue of $145.4 million, marking a 5% year-over-year increase, and an adjusted EBITDA that surpassed expectations. However, the company's guidance for FY27 reve
Minimalist illustration of a heart valve and blood vessel

May 27, 2026

Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June

Cardio Diagnostics Holdings, Inc. is set to showcase its innovative cardiovascular solutions at four key national benefits conferences this June, addressing the critical issue of cardiovascular disease (CVD), a leading cost driver for health plans.The company will present its advanced blood tests, Epi+Gen CHD™ and PrecisionCHD™, which utilize a combination of epigenetics, genetics, and artificial intelligence to identify individuals at risk for severe cardiac events. These tests aim to enhance p
A heart model in a clinical setting with a medical chart in the background.

May 27, 2026

Cardiac AI Diagnostics Clears China Regulatory Gate Via Lishman Global As Edison Award, Northern California Deployment, And Indigenous Partnership Stack Validation

VentriPoint Diagnostics Ltd. is making significant strides in the cardiac AI diagnostics space, recently achieving multiple validation milestones that enhance its market positioning in China and beyond.In a notable development, VentriPoint's VMS+™ 4.0 system has been submitted for regulatory approval to China's National Medical Products Administration (NMPA) via its partner, Lishman Global. This submission benefits from the NMPA's "green channel," which expedites the approval process for innovat
A petri dish with a drug compound in a lab setting

May 27, 2026

Isomorphic Labs has turned AI drug discovery into a 2.1B capital story

Isomorphic Labs has successfully raised $2.1 billion in a Series B funding round, reflecting strong investor confidence in its AI-driven drug discovery platform.The Alphabet-supported company, helmed by Demis Hassabis, announced that the funding will enhance its AI drug design engine, IsoDDE, and expand its global reach while advancing its pipeline towards clinical trials. This significant financial backing, led by Thrive Capital along with other notable investors, underscores a growing belief t
Silhouette of scales of justice representing equity in digital health

May 27, 2026

Penny Kechagioglou: ‘We’ve become too attached to AI’

Dr. Penny Kechagioglou, recognized as Digital Health’s chief clinical information officer of the year, raises critical concerns about the NHS's growing reliance on AI technologies. She emphasizes that while digital innovations hold promise, they risk exacerbating existing health inequalities if not implemented with caution and strong clinical leadership.Kechagioglou, a consultant oncologist at University Hospital Coventry and Warwickshire, warns that the rapid pace of digital transformation may
A minimalist illustration of a stethoscope and AI tool in a dark palette.

May 27, 2026

Andhra Pradesh Sets Benchmark in AI-Driven Healthcare, Says Health Minister

Andhra Pradesh is setting a new standard in AI-driven healthcare, as highlighted by Health Minister Satya Kumar Yadav during a recent conference. The state is leveraging artificial intelligence to enhance diagnostic accuracy and streamline patient treatment.The integration of AI in Andhra Pradesh's healthcare system aims to tackle ten significant diseases, particularly non-communicable ones. This initiative aligns with the broader vision of Viksit Bharat, which seeks to advance healthcare throug